Incorporating Robotic Surgery Into the Management of Ovarian Cancer After Neoadjuvant Chemotherapy

International Journal of Gynecological Cancer- United Kingdom

doi 10.1136/ijgc-2019-000413

Full Text

Abstract

Available in

Date

Authors

Publisher

BMJ

Related search

Neoadjuvant Chemotherapy in the Management of Advanced Ovarian Cancer and Primary Cancer of the Peritoneum: Rationale and Results

2013English

Neoadjuvant Chemotherapy or Primary Surgery for Stage III/IV Ovarian Cancer: Contribution of Diagnostic Laparoscopy

BMC Cancer
Cancer ResearchOncologyGenetics
2009English

Overall Survival Following Neoadjuvant Chemotherapy vs Primary Cytoreductive Surgery in Women With Epithelial Ovarian Cancer

JAMA Oncology
Cancer ResearchOncology
2017English

Towards De-Escalation of Axillary Management After Neoadjuvant Chemotherapy in Breast Cancer

English

Neoadjuvant Chemotherapy for Advanced Epithelial Ovarian Cancer. Who Really Benefits?

Australian and New Zealand Journal of Obstetrics and Gynaecology
MedicineGynecologyObstetrics
2017English

Primary Debulking Surgery Versus Primary Neoadjuvant Chemotherapy for High Grade Advanced Stage Ovarian Cancer: Comparison of Survivals

Radiology and Oncology
Nuclear MedicineRadiologyImagingOncology
2018English

Survival Nomograms After Curative Neoadjuvant Chemotherapy and Radical Surgery for Stage IB2-IIIB Cervical Cancer

Cancer Research and Treatment
Cancer ResearchOncology
2018English

Predicting Successful Conservative Surgery After Neoadjuvant Chemotherapy in Hormone Receptor-Positive, HER2-Negative Breast Cancer

Journal of Breast Disease
2018English

Adjuvant Chemotherapy After Surgery Can Improve Clinical Outcomes for Patients With IB2-IIB Cervical Cancer With Neoadjuvant Chemotherapy Followed by Radical Surgery

Scientific Reports
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy